Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3cly | ACP | Fibroblast growth factor receptor 2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3cly | ACP | Fibroblast growth factor receptor 2 | / | 1.000 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.539 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.500 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.499 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.491 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.483 | |
| 4bn1 | ADP | Aurora kinase A | 2.7.11.1 | 0.483 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.479 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.477 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.473 | |
| 2rc3 | NAD | CBS domain | / | 0.470 | |
| 4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.470 | |
| 4fry | NAD | Putative signal-transduction protein with CBS domains | / | 0.466 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.464 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 4ryv | ZEA | Protein LlR18A | / | 0.462 | |
| 3frq | ERY | Erythromycin resistance repressor protein | / | 0.461 | |
| 2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
| 2y3r | TRK | TamL | / | 0.460 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.459 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.459 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.459 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.457 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
| 4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.456 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.455 | |
| 1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.454 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.454 | |
| 4bwx | AGS | PAB-dependent poly(A)-specific ribonuclease subunit pan3 | / | 0.454 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.453 | |
| 2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 3d8b | ADP | Fidgetin-like protein 1 | 3.6.4 | 0.453 | |
| 4m87 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.453 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
| 1ie4 | T44 | Transthyretin | / | 0.452 | |
| 1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.452 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.452 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
| 3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.452 | |
| 1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.451 | |
| 2y3r | TIR | TamL | / | 0.451 | |
| 3zc3 | NAP | Ferredoxin--NADP reductase | 1.18.1.2 | 0.451 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
| 2y4g | TIR | TamL | / | 0.450 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.450 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.450 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.448 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
| 1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.447 | |
| 1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
| 4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.446 | |
| 3uoy | NAP | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.446 | |
| 3uoz | NAP | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.446 | |
| 4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.446 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.446 | |
| 1wc1 | TAT | Adenylate cyclase | / | 0.445 | |
| 2nnh | REA | Cytochrome P450 2C8 | / | 0.445 | |
| 3keu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.445 | |
| 3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.445 | |
| 3tku | M77 | Serine/threonine-protein kinase MRCK beta | 2.7.11.1 | 0.445 | |
| 4ki8 | ADP | 60 kDa chaperonin | / | 0.445 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.444 | |
| 1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.443 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 4u03 | GTP | Cyclic GMP-AMP synthase | / | 0.443 | |
| 1fm9 | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.442 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
| 1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
| 4h6r | FDA | Proline dehydrogenase | / | 0.442 | |
| 1lrl | UPG | UDP-glucose 4-epimerase | 5.1.3.2 | 0.441 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
| 4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.441 | |
| 2gmh | FAD | Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial | 1.5.5.1 | 0.440 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.440 | |
| 3t14 | FAD | Sulfide-quinone reductase | / | 0.440 | |
| 4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.440 |